Healthcare and Life Science
Quantifying public and private investment in European biopharmaceutical research and development
This peer-reviewed paper was published in the June 2024 issue of Health Affairs Scholar. ...
500 patients benefit from Trust’s life-saving robots
Addenbrooke’s three surgical robots have helped specialists carry out nearly 540 life-saving or life altering operations in the last 12 months. ...
Thousands of high-risk cancer gene variants identified
Over 5,000 genetic variants that enable certain cancers to thrive have been identified by scientists, along with a potential therapeutic target to treat or even prevent these cancers from developing. ...
Guardtech Summer Update: Group looking strong on all construction fronts
Suffolk-based cleanroom installation experts undertaking complex projects both at home and overseas as the Summer season heats up. ...
Western superbugs do not dominate in Pakistan
Certain antibiotic-resistant strains of bacteria endemic to the UK, Norway and the USA have not taken hold in Pakistan despite the widespread use of antibiotics in this region. ...
Cutting-edge genomic test can improve care of children with cancer
Whole genome sequencing has improved clinical care of some children with cancer in England by informing individual patient care. ...
Optibrium demonstrates accelerated lead optimisation in complex agrochemical development
Optibrium’s QuanSA 3D-QSAR method uses an active learning approach to successfully and more efficiently identify a mimic of a macrocyclic natural product ...
Cellular Origins acquires ACTIA Platform IP to enhance automated cell therapy manufacturing
Autologous Cell Therapy Industrial Automation (ACTIA) strengthens technology and IP portfolio of Cellular Origins supporting ongoing development and expanding capabilities of Constellation platform ...
Nxera Pharma receives US$10 million from AbbVie as collaboration targeting neurological diseases achieves first R&D milestone
Tokyo, Japan and Cambridge, UK, 27 June 2024 - Nxera Pharma Co. Ltd, announces that it has reached an important R&D milestone under its multi-target discovery collaboration with AbbVie targeting neurological diseases, resulting in a payment of US$10 million to Nxera. Nxera and Abb...
Bio-Rad launches ChemiDoc Go Imaging System
Compact system uses CMOS Digital Imaging and is compatible with chemiluminescence and fluorescence detection and stain-free technology HERCULES, Calif. — July 1, 2024 — Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostics products, announces ...